Blog Page 2

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government.

Click the patents below for more details, or visit TechTransferWatch.com for more options.

Conformationally restricted urea inhibitors of soluble epoxide hydrolase
University of California
Patent number: 9,029,550
Issue Date: May 12, 2015


Synthetic genes and genetic constructs
Commonwealth Scientific and Industrial Research Organisation
Patent number: 9,029,527
Issue Date: May 12, 2015


Signal activated RNA interference
Si-Ping Han, Robert D. Barish, William A. Goddard, III
California Institute of Technology
Patent number: 9,029,524
Issue Date: May 12, 2015


Anti-EGFR antibody and use thereof
Nobuyoshi Shimizu, Atsushi Takayanagi, Tetsuhiko Yoshida
Keio University
Patent number: 9,029,513
Issue Date: May 12, 2015


Method for native ligation of polypeptides
Oleg Melnyk, Reda Mhidia, Julien Dheur, Nathalie Ollivier, Oleg Melnyk, Reda Mhidia, Julien Dheur, Nathalie Ollivier
Institut Pasteur
Patent number: 9,029,503
Issue Date: May 12, 2015


Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
Mukesh K. Nyati, Theodore S. Lawrence
University of Michigan
Patent number: 9,029,502
Issue Date: May 12, 2015


Methods of treatment of skin ulcers
Robert Wilensky, Damir Hamamdzic, Harrilla Profka
University of Pennsylvania
Patent number: 9,029,383
Issue Date: May 12, 2015


Xenobiotic related induction of gene expression
Christopher Liddle, Bryan James Goodwin
University of Sydney
Patent number: 9,029,336
Issue Date: May 12, 2015


Cross-linked peptides and proteins, methods of making same, and uses thereof
Qing Lin, Avinash Muppidi
State University of New York System
Patent number: 9,029,332
Issue Date: May 12, 2015


Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
Steven M. Jay, Linda G. Griffith, Richard T. Lee
Massachusetts Institute of Technology
Patent number: 9,029,328
Issue Date: May 12, 2015


Methods and compositions for enhanced differentiation from embryonic stem cells
Clark K. Colton, Daryl E. Powers, Jeffrey R. Millman
Massachusetts Institute of Technology
Patent number: 9,029,147
Issue Date: May 12, 2015


Mesenchymal stem cell conditioned medium
Sai Kiang Lim, Elias Lye
Agency for Science, Technology and Research
Patent number: 9,029,146
Issue Date: May 12, 2015


Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
Brendon Stewart Noble, David Matthew Pier
University of Edinburgh
Patent number: 9,029,145
Issue Date: May 12, 2015


Method of degrading TBP using a photosynthetic bacterial strain
Daniel Garcia, Cécile Berne
Commissariat a l’Energies Atomique et aux Energies Alternatives
Patent number: 9,029,127
Issue Date: May 12, 2015


Composition for the cultivation of sophisticated bacteria
Volkhard Kempf
Eberhard Karls University of Tübingen
Patent number: 9,029,119
Issue Date: May 12, 2015


Microfluidic vortex-assisted electroporation system and method
Harvard
Patent number: 9,029,109
Issue Date: May 12, 2015


Vitro evolution in microfluidic systems
Andrew David Griffiths, David Weitz, Darren Link, Keunho Ahn, Jerome Bibette
Harvard
Patent number: 9,029,083
Issue Date: May 12, 2015


Vaccine against
Roland Contreras, Kristof De Vusser, Silvia Revelli
Ghent University
Patent number: 9,028,844
Issue Date: May 12, 2015


Methods and compositions for poxvirus A35R protein
East Carolina University
Patent number: 9,028,837
Issue Date: May 12, 2015


Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
Chi-Huey Wong, Chung-Yi Wu, Alice L. Yu, John Yu
Academia Sinica
Patent number: 9,028,836
Issue Date: May 12, 2015


Antibodies binding to adrenomedullin receptors and uses thereof as drugs
L’Houcine Ouafik, Kamel Mabrouk, Itidal Kaafarany, Pierre-Marie Martin
Aix-Marseille University
Patent number: 9,028,818
Issue Date: May 12, 2015


DrugPatentWatchdrugpatentwatch-pin has expanded its global coverage of pharmaceutical patents by adding coverage of Supplementary Protection Certificates.

DrugPatentWatch provides deep knowledge on pharmaceutical drugs and the 90,000 global patents covering them. Uses cases include:

Payers: Formulary and pharmacy & therapeutics (P&T)

Anticipate future budget requirements and proactively identify generic sources

Branded pharmaceutical manufacturers

Assess past successes of patent challengers and elucidate research paths of competitors

Specialty pharmaceuticals and generics

Identify market entry opportunities and inform portfolio management decisions

Buyers, wholesalers, and distributors

Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs

API manufacturers

Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers

The addition of Supplementary Protection Certificates expands coverage of European markets, and helps identify drugs which have these patent extensions.

For more information see www.DrugPatentWatch.com or sign up for a free trial at www.DrugPatentWatch.com/trial.php

Drug Patent Expirations for May 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
ACCUPRIL Pfizer Pharms quinapril hydrochloride 5,684,016*PED May 4, 2015
INTEGRILIN Schering eptifibatide 5,747,447 May 5, 2015
LIPTRUZET Merck Sharp Dohme atorvastatin calcium; ezetimibe 5,686,104*PED May 11, 2015
LIPITOR Pfizer atorvastatin calcium 5,686,104*PED May 11, 2015
CADUET Pfizer amlodipine besylate; atorvastatin calcium 5,686,104*PED May 11, 2015
AFREZZA Sanofi Aventis insulin recombinant human 6,071,497 May 15, 2015
AFREZZA Sanofi Aventis insulin recombinant human 6,428,771 May 15, 2015
AFREZZA Sanofi Aventis insulin recombinant human 8,394,414 May 15, 2015
RISPERDAL CONSTA Janssen Pharms risperidone 5,688,801*PED May 18, 2015
SANDOSTATIN LAR Novartis octreotide acetate 5,688,530*PED May 18, 2015
ZYVOX Pharmacia And Upjohn linezolid 5,688,792*PED May 18, 2015
ASMANEX TWISTHALER Merck Sharp Dohme mometasone furoate 5,687,710*PED May 18, 2015
MACUGEN Valeant Pharms Llc pegaptanib sodium 6,051,698 May 19, 2015
LIVALO Kowa Co pitavastatin calcium 5,753,675 May 19, 2015
OCTREOSCAN Mallinckrodt indium in-111 pentetreotide kit 5,753,627 May 19, 2015
NEXIUM 24HR Astrazeneca Lp esomeprazole magnesium 5,690,960*PED May 25, 2015
NEXIUM Astrazeneca Pharms esomeprazole magnesium 5,690,960*PED May 25, 2015
EGRIFTA Theratechnologies tesamorelin acetate 5,861,379 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 8,017,105 May 26, 2015
EGRIFTA Theratechnologies tesamorelin acetate 6,020,311 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 7,229,606 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 7,060,250 May 26, 2015
NEXIUM IV Astrazeneca Pharms esomeprazole sodium 6,143,771 May 27, 2015
SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS Us Army perfluoropolymethylisopropyl ether; polytetrafluoroethylene 5,607,979 May 30, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

ACCUPRIL (quinapril hydrochloride)
Pfizer Pharms
Patent number: 5,684,016
Expiration Date: May 4, 2015


INTEGRILIN (eptifibatide)
Schering
Patent number: 5,747,447
Expiration Date: May 5, 2015


For more information try a free trial

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government.

Click the patents below for more details, or visit TechTransferWatch.com for more options.

Antisense oligonucleotides for inducing exon skipping and methods of use thereof
University of Western Australia
Patent number: 9,024,007
Issue Date: May 05, 2015


Compound for use in peptide synthesis
Chuan Fa Liu
Nanyang Technological University
Patent number: 9,023,957
Issue Date: May 05, 2015


Materials and methods related to modulation of mismatch repair and genomic stability by miR-155
Ohio State University
Patent number: 9,023,825
Issue Date: May 05, 2015


Micro-RNA’s that regulate muscle cells
University of Texas System
Patent number: 9,023,823
Issue Date: May 05, 2015


Use of MicroRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells
Brice Marcet, Pascal Barbry, Rainer Waldmann, Bernard Mari, Christelle Coraux
Centre National de la Recherche Scientifique
Patent number: 9,023,821
Issue Date: May 05, 2015


Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
Arnaud Bocquet, Joël Eyer, Alan Peterson, Arnaud Bocquet, Joël Eyer, Alan Peterson, Arnaud Bocquet, Joël Eyer, Alan Peterson
University of Angers
Patent number: 9,023,806
Issue Date: May 05, 2015


Peptides for the treatment of oxidative stress related disorders
Daniel Offen, Nirit Lev, Eldad Melamed
Tel Aviv University
Patent number: 9,023,800
Issue Date: May 05, 2015


Method of labeling sulfenic acid-containing proteins and peptides
Cristina M. Furdui, Allen W. Tsang, Jiang Qian
Wake Forest University Health Sciences
Patent number: 9,023,653
Issue Date: May 05, 2015


RNA-guided human genome engineering
Harvard
Patent number: 9,023,649
Issue Date: May 05, 2015


FGF having enhanced stability
Wisconsin Alumni Research Foundation
Patent number: 9,023,644
Issue Date: May 05, 2015


Method and apparatus for a miniature bioreactor system for long-term cell culture
Stanley J. Kleis, Sandra K. Geffert, Steve R. Gonda
University of Houston System
Patent number: 9,023,642
Issue Date: May 05, 2015


Systems and methods for biotransformation of carbon dioxide into higher carbon compounds
Justin Siegel, David Baker, Amanda Lee Smith, Mary E. Lidstrom, Catherine Louw
University of Washington
Patent number: 9,023,627
Issue Date: May 05, 2015


Recombinant pokeweed antiviral proteins, compositions and methods related thereto
Colorado State University
Patent number: 9,023,596
Issue Date: May 05, 2015


Continuous directed evolution of proteins and nucleic acids
David R. Liu, Kevin M. Esvelt
Harvard
Patent number: 9,023,594
Issue Date: May 05, 2015


Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus
Tadahito Kanda, Kazunari Kondo
Japan Health Sciences Foundation
Patent number: 9,023,364
Issue Date: May 05, 2015


Anti-(+)—methamphetamine monoclonal antibodies
University of Arkansas
Patent number: 9,023,353
Issue Date: May 05, 2015


Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
Yoram Reiter, Cyril Cohen
Technion
Patent number: 9,023,348
Issue Date: May 05, 2015


Journal of Commercial Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Financial accounts reports

Go to paper

ABSTRACT: Basilea Pharmaceutica AG is a Swiss-based biotechnology company whose shares are traded on the Swiss Stock Exchange. It is developing antibacterial and antifungal drugs along with dermatology treatments. The company was founded in October 2000 as a wholly owned subsidiary of F. Hoffmann-La Roche, which subsequently sold over half of the company's shares to other investors but retained approximately 33 per cent of the company at 31st December, 2004...

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website

Journal of Commercial Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Financial accounts reports

Go to paper

ABSTRACT: Basilea Pharmaceutica AG is a Swiss-based biotechnology company whose shares are traded on the Swiss Stock Exchange. It is developing antibacterial and antifungal drugs along with dermatology treatments. The company was founded in October 2000 as a wholly owned subsidiary of F. Hoffmann-La Roche, which subsequently sold over half of the company's shares to other investors but retained approximately 33 per cent of the company at 31st December, 2004...

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website

The Journal of Commercial Biotechnology is seeking applications for the position of Managing Editor.

Responsibilities

The Journal of Commercial Biotechnology has been described as “a Harvard Business Review for Biotechnology Companies.” The Managing Editor should seek to maintain this editorial focus and strong standing through:

– Solicitation of papers in line with the JCB’s editorial focus

– Managing peer review of submitted papers

– Writing editorials in timely biotechnology industry topics

– Representing the JCB at conferences

Experience

This is a part-time post.

The ideal candidate will have primary appointment at a top-flight academic institution, or a commercial enterprise with the ability to dedicate time to meeting the responsibilities noted above.

About the Journal of Commercial Biotechnology

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

To Apply

Send a cover letter using the contact form at thinkbiotech.com.

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

LAMISIL (terbinafine)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


LAMISIL AT (terbinafine hydrochloride)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


LAMISIL AT (terbinafine)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


MAVIK (trandolapril)
Abbvie
Patent number: 5,744,496
Expiration Date: Apr 28, 2015


For more information try a free trial

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government.

Click the patents below for more details, or visit TechTransferWatch.com for more options.

Soybean variety ‘G04-1618RR’
University of Georgia
Patent number: 9,018,455
Issue Date: April 28, 2015


Non-diffusing plant virus vector
Noriho Fukuzawa, Takeshi Matsumura, Noriko Itchoda, Takeaki Ishihara, Chikara Masuta, Noriho Fukuzawa, Takeshi Matsumura, Noriko Itchoda, Takeaki Ishihara, Chikara Masuta
Japan National Institute of Advanced Industrial Science and Technology
Patent number: 9,018,444
Issue Date: April 28, 2015


Antisense oligonucleotides for inducing exon skipping and methods of use thereof
University of Western Australia
Patent number: 9,018,368
Issue Date: April 28, 2015


Single stranded DNA aptamers binding NF-κB/RelA
Steven G. Widen, Thomas G. Wood, Allan R. Brasier, Yingxin Zhao
University of Texas System
Patent number: 9,018,367
Issue Date: April 28, 2015


DC-STAMP antibodies
Edward M. Schwarz, Kofi A. Mensah, Yahui Grace Chiu, Christopher T. Ritchlin
University of Rochester
Patent number: 9,018,358
Issue Date: April 28, 2015


Methods of producing proteins having triple-helix structure
Tetsuo Kase, Akio Kimura, Hiroshi Ueyama, Mizuki Nishihara, Yoko Kisaki
Osaka Prefectural Government
Patent number: 9,018,354
Issue Date: April 28, 2015


Method of treating hyperproliferation of cells using a nucleolin specific aptamer
Pohang University of Science and Technology
Patent number: 9,018,186
Issue Date: April 28, 2015


Method of diagnosing cancer using a nucleolin specific aptamer
Pohang University of Science and Technology
Patent number: 9,018,185
Issue Date: April 28, 2015


Materials and methods for suppressing inflammatory and neuropathic pain
Rajesh Khanna
Indiana University
Patent number: 9,018,173
Issue Date: April 28, 2015


Modification of peptides via S
Bradley L. Pentelute, Alexander M. Spokoyny, Yekui Zou, Chi Zhang
Massachusetts Institute of Technology
Patent number: 9,018,172
Issue Date: April 28, 2015


Peptides for suppressing inflammation
Daniel T. Laskowitz, Hana Dawson, Brad Kolls
Duke University
Patent number: 9,018,169
Issue Date: April 28, 2015


Glucagon analogs exhibiting physiological solubility and stability
Richard D. DiMarchi, David L. Smiley
Indiana University
Patent number: 9,018,164
Issue Date: April 28, 2015


Modulating PDX-1 with PCIF1, methods and uses thereof
Doris Stoffers
University of Pennsylvania
Patent number: 9,018,163
Issue Date: April 28, 2015


Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using MFG-E8
Ping Wang
Feinstein Institute for Medical Research
Patent number: 9,018,157
Issue Date: April 28, 2015


Compositions and methods for generating and screening adenoviral libraries
Shawn E. Lupold, Ronald Rodriguez, Wasim H. Chowdhury, Tarana A. Kudrolli
Johns Hopkins University
Patent number: 9,018,138
Issue Date: April 28, 2015


Gamma satellite insulator sequences and their use in preventing gene silencing
Jung-Hyun Kim, Vladimir L. Larionov, Tom Ebersole
Department of Health and Human Services
Patent number: 9,018,011
Issue Date: April 28, 2015


Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
Michal Amit, Joseph Itskovitz-Eldor
Technion
Patent number: 9,018,010
Issue Date: April 28, 2015


Three-dimensional scaffold and method of manufacturing the same
Dong-Woo Cho, Jong Young Kim, Jin-Hyung Shim
Pohang University of Science and Technology
Patent number: 9,018,008
Issue Date: April 28, 2015


Method of deriving progenitor cell line
Sai Kiang Lim, Elias Lye
Agency for Science, Technology and Research
Patent number: 9,018,005
Issue Date: April 28, 2015


Method of expanding double negative T cells
Li Zhang, Mei Han, Pouneh Dokouhaki
University Health Network
Patent number: 9,018,004
Issue Date: April 28, 2015


Method to trigger RNA interference
Oregon State University
Patent number: 9,018,002
Issue Date: April 28, 2015


Importation of mitochondrial protein by an enhanced allotopic approach
Marisol Corral-Debrinski, Jose-Alain Sahel, Valerie Kaltimbacher, Crystel Bonnet
Institut National de la Sante et de la Recherche Medicale
Patent number: 9,017,999
Issue Date: April 28, 2015


Expression of proteins in plants
University of Cape Town
Patent number: 9,017,987
Issue Date: April 28, 2015


Non-wild-type organophosphorus acid anhydrolases for enzymatic decontamination
United States Army
Patent number: 9,017,982
Issue Date: April 28, 2015


Sugar-chain modified yeast and method for producing glycoprotein using the same
Hiroko Abe, Kazuya Tomimoto, Yasuko Fujita, Tomoko Iwaki, Yasunori Chiba, Yoshihiro Nakajima, Kenichi Nakayama, Masatoshi Kataoka, Shouki Yatsushiro, Shohei Yamamura
Japan National Institute of Advanced Industrial Science and Technology
Patent number: 9,017,969
Issue Date: April 28, 2015


Biomarker and therapeutic for urinary tract infection
Washington University
Patent number: 9,017,953
Issue Date: April 28, 2015


HIV-1 latency model for high throughput screening
Joseph P. Dougherty, Sofiya Micheva-Viteva, Stuart W. Peltz, Yacov Ron, Annmarie Pacchia
University of Medicine & Dentistry of New Jersey
Patent number: 9,017,935
Issue Date: April 28, 2015


Glucose biofuel cell
Philippe Cinquin, Chantal Gondran, Fabien Giroud, Serge Cosnier
Universite Joseph Fourier
Patent number: 9,017,884
Issue Date: April 28, 2015


Pathway for Th-17 cell development and methods utilizing same
Casey T. Weaver, Paul R. Mangan, Laurie E. Harrington
University of Alabama, Birmingham
Patent number: 9,017,685
Issue Date: April 28, 2015


Diagnosis and treatment of cancer using anti-EREG antibody
Hiroyuki Aburatani, Hirotaka Ito, Kenji Yoshida
University of Tokyo
Patent number: 9,017,684
Issue Date: April 28, 2015


Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
Vafa Shahabi, Anu Wallecha, Paulo C. Maciag, Yvonne Paterson, Nicola Mason, Matthew Seavey
University of Pennsylvania
Patent number: 9,017,660
Issue Date: April 28, 2015


Preparation system and method
National Aeronautics and Space Administration
Patent number: 9,017,621
Issue Date: April 28, 2015